Trials / Completed
CompletedNCT03596996
Optimizing Iron Status While Minimizing Morbidity in HIV-infected Ugandan Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 6 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, placebo-controlled trial of the effect of 84 days of daily iron supplementation on iron status, gut microbiome profile, infectious disease frequency, and HIV disease severity in moderately anemic \[hemoglobin 9 - \<11 g/dL (6-59 mo); hemoglobin 9 - \< 11.5 g/dL (5 -12 years)\], HIV-infected Ugandan children between the ages of 6 mos and 12 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ferrous Sulfate | Ferrous sulfate dosed by WHO guidelines by age for the prevention of iron deficiency and anemia. |
| DIETARY_SUPPLEMENT | Placebo | Placebo with identical appearance comparison intervention arm |
Timeline
- Start date
- 2018-04-19
- Primary completion
- 2020-02-10
- Completion
- 2020-02-10
- First posted
- 2018-07-24
- Last updated
- 2020-08-21
Locations
1 site across 1 country: Uganda
Source: ClinicalTrials.gov record NCT03596996. Inclusion in this directory is not an endorsement.